Mark Leschly Cara Therapeutics, Inc

As of April 3, 2017


Mark Leschly Net Worth

  • Net worth is estimated to be at least $319.15M
  • Owns at least 3,568,057 units of Cara Therapeutics, Inc stock

Mark Leschly Trading

  • Largest purchase of shares was 500,000 units , worth over $9.1M on April 3, 2017
  • In total has made about 3 transactions over 3 years
  • Usually trades in March, April and February, with the busiest year in 2014, 2016 and 2017

RHO Ventures VI LP, RMV VI LLC, Rho Capital Partners LLC, MARK LESCHLY, HABIB KAIROUZ, JOSHUA RUCH

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Mark Leschly Mailing Address

  • Mailing address is Rho Capital Partners, Inc. 152 W 57th St23rd Fl New York NY 10019 NY

Cara Therapeutics, Inc Insider Trading

  • The most recent transaction was 8,180 units sold on November 16, 2021 by Jeffrey Ives worth over $131.21K
  • In the last 7 years, insiders at Cara Therapeutics, Inc sold an estimated value of $26.24M and bought an estimated value of $21.17M
  • The most active traders are Phd Frederique Menzaghi, Chief Scientific OffSVP-R&D,  Derek Chalmers, President & CEO,  and Jeffrey Ives, Director
  • Insider trading is most common in June, with the busiest year in 2020

Cara Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1